Henry DeArcia, child life specialist who works in the Pediatric Hematology/Oncology Clinic, was given the UNC Rehabilitation Service Line the 2022 “Unsung Hero Award.” Congratulations, Henry!! Thank you for all you do for our patients.
Check out this link to a newly published article! Our physical therapist, Jennifer Newman, is 1st author! Congratulations Jennifer on all the hard work that went into this! Click on the title of this story for a link to the article.
We have a new program manager!!! As many of you know, Fran Davis retired in late December. While we wish Fran all the best, we are very excited to welcome Joyce Mauban to our team. Welcome to the UNC Hemophilia Treatment Center, Joyce!
Nurse Elise had her baby this week!!! Everyone is well and we are so excited for the new addition to her family and to ours!! She plans to be back in the spring and looks forward to seeing you all then! Congratulations Nurse Elise!!!!
Dr. Ma has been awarded the 2018 Hyman L. Battle Distinguished Excellence in Teaching Award in the Basic Sciences. Faculty are nominated by departments and students, and the recipient is selected by students who have completed the second year. Alice D. Ma, MD, describes herself as the queen of mnemonics and analogies, explaining difficult concepts …
A multi-center retrospective chart review provided greater detail about the development and diagnosis of the disorder in childhood and points the way toward a better understanding of screening those at risk.
UNC Hemophilia and Thrombosis Center Director Nigel Key, MB, CHB, FRCP, participated in the UNC Department of Medicine Grand Rounds Lecture Series on April 18, 2018 with a talk entitled "Hemophilia: A 100-Year Story."
Stephan Moll, MD, professor of medicine and member of the UNC Hemophilia and Thrombosis Center, co-authored the results of a large-scale multicenter clinical trial focusing on catheter-directed thrombolysis and its effects.
In August 2017, Pfizer committed to building a $100 million gene therapies plant in North Carolina and, in exchange, North Carolina committed to providing the drugmaker with a quarter-million dollars' worth of help. Pfizer will expand an 11,000-square-foot plant in Sanford, North Carolina that it acquired last year when it bought gene therapies biotech Bamboo Therapeutics in a deal valued at up to $688 million. Bamboo bought the facility last year from the University of North Carolina about the time that Pfizer made its initial investment in the company.
Cure HHT to Present Congressman David E. Price with its "Champion Award" at Launch of Multi-State Pilot Program Headquartered at UNC Chapel Hill